Last reviewed · How we verify
Recombinant Influenza Vaccine
Recombinant Influenza Vaccine is a Biologic drug developed by Insight Therapeutics, LLC. It is currently FDA-approved. Also known as: Flublok, RIV4, FluBlok.
At a glance
| Generic name | Recombinant Influenza Vaccine |
|---|---|
| Also known as | Flublok, RIV4, FluBlok |
| Sponsor | Insight Therapeutics, LLC |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- pH1N1 Blinded Challenge Study (PHASE1)
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine (PHASE1, PHASE2)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
- Vaccine Responses in Patients With B Cell Malignancies (PHASE4)
- A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. (PHASE1)
- Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study (PHASE4)
- Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant Influenza Vaccine CI brief — competitive landscape report
- Recombinant Influenza Vaccine updates RSS · CI watch RSS
- Insight Therapeutics, LLC portfolio CI
Frequently asked questions about Recombinant Influenza Vaccine
What is Recombinant Influenza Vaccine?
Recombinant Influenza Vaccine is a Biologic drug developed by Insight Therapeutics, LLC.
Who makes Recombinant Influenza Vaccine?
Recombinant Influenza Vaccine is developed and marketed by Insight Therapeutics, LLC (see full Insight Therapeutics, LLC pipeline at /company/insight-therapeutics-llc).
Is Recombinant Influenza Vaccine also known as anything else?
Recombinant Influenza Vaccine is also known as Flublok, RIV4, FluBlok.
What development phase is Recombinant Influenza Vaccine in?
Recombinant Influenza Vaccine is FDA-approved (marketed).
Related
- Manufacturer: Insight Therapeutics, LLC — full pipeline
- Also known as: Flublok, RIV4, FluBlok
- Compare: Recombinant Influenza Vaccine vs similar drugs
- Pricing: Recombinant Influenza Vaccine cost, discount & access